Hair Regeneration in Androgenetic Alopecia
Androgenetic Alopecia
About this trial
This is an interventional treatment trial for Androgenetic Alopecia focused on measuring Secretome, Minoxidil, Skin, Androgenetic alopecia
Eligibility Criteria
Inclusion Criteria: Male patients aged 18-59 years Clinical presentation of AGA with Hamilton-Norwood Grade III-VI Willing to be a research subject, sign a consent form, and commit to regular follow-up visits Exclusion Criteria: Hair loss other than AGA, including telogen effluvium, alopecia areata, trichotillomania, secondary syphilis, systemic lupus erythematosus hair loss due to chemotherapy, autoimmune conditions, or malignancies. Patients taking oral medications or vitamins aimed at increasing hair growth in the last month Patients applying topical medications aimed at increasing hair growth in the last 2 weeks Patients with active bacterial, viral, or fungal infections on the scalp Patients undergoing AGA therapy cosmetic procedures in the form of PRP injections, laser procedures, or micro-needling in the last 3 months
Sites / Locations
- RSUP Nasional Cipto Mangunkusumo
- Universitas Indonesia
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Minoxidil
Secretome from Adipose-Derived Stem Cells
Minoxidil + Secretome
The drug used is minoxidil 5% solutions for topical use, 1 cc, 2 times a day, every day for 12 weeks
Secretom concentrate of Adipose-Derived Stem Cells (ADSCs) 2cc, injected to the scalp on weeks 0, 4, and 8 of the study
The subject received both minoxidil and secretome from ADSCs, with the same dosage form, dosage, frequency, and duration